Virtual event

Virtual event

Metabolomics of infectious diseases – COVID-19 and beyond

During this event you will learn

  • Why metabolism is vital in the regulation of immune responses
  • How lipid signatures differ depending on COVID-19 severity
  • How metabolism can hint at the outcome in critically-ill patients
Name*
E-Mail*
Country/Region
Field of research interest

By entering your contact details left you agree to our Privacy policy.

Metabolomics of infectious diseases – COVID-19 and beyond

Name*
E-Mail*
Land/Region
Field of research interest

By entering your contact details left you agree to our Privacy policy.

Agenda

04:00 pm CET

Welcome & Introduction
Local or systemic effects – what drives outcome in infectious diseases?

Mag. Stefan Ledinger, BSc

Director Business Development
biocrates life sciences ag, Innsbruck, Austria

04:10 pm CET

COVID-19 infection results in alterations of the kynurenine pathway and fatty acid metabolism as a function of biological and clinical correlates

Dr. Julie A. Reisz Haines

University of Colorado Anschutz Medical Campus, Aurora, USA

04:35 pm CET

Lipidomics- and metabolomics based stratification of COVID-19 patients

Dr. Marianna Caterino

CEINGE-Biotecnologie Avanzate,
University of Naples, Italy

05:00 pm CET

Could metabolomics assist disease management in
critically-ill COVID-19 patients?

Dr. Mohamed A. Elrayess

Biomedical Research Center (BRC), Qatar University, Qatar 

05:25 pm CET

Conclusion and wrap-up

Dr. Kathrine Black

Business Development Manager
biocrates inc., Laguna Hills, USA

Mag. Stefan Ledinger, BSc

Director Business Development
biocrates life sciences ag, Innsbruck, Austria